JAK-STAT1 as therapeutic target for EGFR deficiency-associated inflammation and scarring alopecia.
Strobl K, Klufa J, Jin R, Artner-Gent L, Krauß D, Novoszel P, Strobl J, Stary G, Vujic I, Griss J, Holcmann M, Farlik M, Homey B, Sibilia M, Bauer T.
Strobl K, et al. Among authors: jin r.
EMBO Mol Med. 2024 Nov 9. doi: 10.1038/s44321-024-00166-3. Online ahead of print.
EMBO Mol Med. 2024.
PMID: 39521937
Free article.